Institutional Biosafety Review
Some research activities—especially those involving genetically modified organisms, infectious agents, or certain biological materials—can carry risks to researchers, the public, or the environment. To help ensure safety and compliance, these projects may require review by the Institutional Biosafety Committee (IBC).
The Institutional Biosafety Committee is the National Institutes of Health-required review board for all research involving recombinant or synthetic nucleic acid molecules. The IBC evaluates whether research involving biohazardous materials is being conducted safely and responsibly. This review process helps protect everyone involved and ensures that research follows federal guidelines and best practices. If you’re starting a project that may involve biological risks, the Institutional Biosafety Review team is here to support you every step of the way.
About
The Institutional Biosafety Committee (IBC) reviews research involving biological materials to ensure safety, compliance, and responsible science. Learn more about IBC operation.
Guidance & Forms
Access essential biosafety guidance and required forms to support your research and ensure compliance with IBC review procedures.
MyIBC
Use the MyIBC system to submit protocols, track review status, and manage your biosafety compliance online.
Training
Find required training and browse our library of recorded IBC training sessions to stay informed on biosafety practices, protocol requirements, and committee procedures.